Synnovation Therapeutics
PrivateLast Round
Series A
Jan 24, 2024
Total Funding Raised
$139M
Company Overview
Synnovation Therapeutics is a biotechnology company that develops precision therapies aimed at treating well-established disease targets through small molecule therapies optimized for key cancer mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synnovation Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Synnovation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 24, 2024 | ||||
| Series A | May 24, 2023 | ||||
| Seed | Nov 26, 2021 |
Synnovation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sirona Capital | Series A |
| Lilly Asia Ventures | Series A |
| Cormorant Asset Management | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Acquired Excellergy Inc. for $2 billion.
- Mar 20, 2026
Novartis acquired PI3Kα inhibitor program for $3 billion.
Synnovation Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synnovation Therapeutics's valuation, stock price, and market status.
